Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

Hosted by the Tulane University Center for Continuing Education, seminar brings together leading researchers and clinicians ...

"Dry January" is a social movement encouraging sobriety for the month. More people, especially younger adults, are choosing ...